Pune, India, May 27, 2021 (GLOBE NEWSWIRE) -- The global ”cell lysis“ market size is projected to grow at an excellent pace owing to the increasing prevalence of cancer worldwide, states Fortune Business Insights™ in its report, titled “Cell Lysis Market Size, Share & Industry Analysis, By Product Type (Instruments, Reagents & Consumables), By Cell Type (Mammalian Cells, Plant Cells, Bacterial Cells, Others (Yeast/Algae/Fungi)), By Application (Protein Isolation, Cell Organelle Isolation, Nucleic Acid Isolation, Others), By End-User (Academics & Research Institutes, Hospitals & Diagnostic Labs, Pharmaceutical & Biotechnology Companies) and Regional Forecast, 2020-2027”.
According to the International Agency for Research on Cancer (IARC) under the World Health Organization (WHO), in 2018, the global burden of cancer grew to 18.1 million new cases and 9.6 million deaths. Cancer is classified as a chronic disease, requiring heavy medication and different therapies. During cancer treatment, cancer cells break down and die and release various substances into the patient’s bloodstream. If these substances are released rapidly, the kidneys are unable to remove them out of the body, leading to cell lysis, which can have toxic effects on the body such as seizures, arrhythmias, and multi-organ failure.
Request a Sample Copy of the Research Report:
https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/cell-lysis-market-103348
To prevent such adverse events, intense research is being undertaken by academic institutions, government bodies, and private research organizations to develop cell lysis methods that can control the death rate of cancer cells. Controlled release of toxic substances from these cells will enable the body’s natural mechanisms to effectively eject these materials fromthe body and restore the health of the patient.
List of Key Players Profiled in the Cell Lysis Market Report:
- F. Hoffmann-La Roche Ltd
- Cell Signaling Technology, Inc.
- Bio-Rad Laboratories, Inc.
- QIAGEN
- Beckman Coulter, Inc.
- BD
Out research methodology is robust and includes data triangulation based on bottom-up and top-down approaches. We validated the approximate market number with the help of primary research. Secondary research was conducted to find out detailed information about mergers & acquisitions, collaborations, joint ventures, and agreements. At the same time, we have derived significant information about the market dynamics associated with growth drivers, trends, and obstacles.
The recent coronavirus outbreak has brought major businesses to a standstill. Due to travel bans, companies in this sector are likely to take a huge hit in the coming years. Ultimately, the rapid spread of the disease has urged governments to take strict measures. The report includes the impact on Covid-19 pandemic on the global market and discusses how major companies are coping with this.
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing. The financial parameters which are assessed include the sales, profits and the overall revenue generated by the key players of Market. Furthermore, the report offers a detailed analysis and information as per Market Growth Analysis by manufacturers, market segments helping our readers to get a comprehensive overview of the global market. Several players are planning to focus on developing cost-effective products or services, aiming to maintain a strong foothold in the market.
To get the short-term and long-term impact of COVID-19 on this Market.
Please visit: https://www.fortunebusinessinsights.com/cell-lysis-market-103348
What Does This Report Offer?
- Unparalleled intelligence into the market drivers, trends, opportunities, and hindrances;
- In-depth diagnosis of all market segments, individually and collectively;
- Industry-leading analysis of the regional dynamics influencing market growth; and
- Exhaustive evaluation of the key players’ profiles and growth strategies.
Reduced Funding for Biomedical Research amid COVID-19 to Stall Market Growth
The COVID-19 pandemic has caused major disruptions in the funding plans of some of the largest biomedical research organizations in the world. For example, in April 2020, Cancer Research UK (CRUK), the charity organization that funds most of the cancer research conducted in the UK, announced that it will have to cut its research budget by 10% due to the coronavirus. Furthermore, it expects its fundraising income to fall by 20% in 2020-21, a decline of £120 million. In the same month, Canada’s foremost cancer research funding agency, the Canadian Institutes of Health Research, announced the cancelation of a major funding round for 2,300 investigators. The Canadian Cancer Society, on the other hand, forecasts that its donations will drop by CAD 100 million as businesses are undergoing a severe downturn because of the COVID-19 pandemic. The development of cell lysis treatments will inevitably suffer from such research spending cuts and affect the growth of the market in the immediate future.
Heavy Investments in Biomedical Research to Propel the Market in North America
North America is expected to lead the cell lysis market share in the forthcoming years owing to the massive investments by research institutes in the region in the field of biomedicine, biotechnology, and healthcare. For example, even amid the coronavirus pandemic, the American Cancer Society approved 79 research and training grants, amounting to USD 36 million in 2020.
In Europe, the market will be mainly driven by the rising prevalence of chronic conditions and an increasing geriatric population. In Asia Pacific, on the other hand, increasing prevalence of cancer, improving healthcare facilities, and expanding funding for medical research will fuel the regional market growth.
Have Any Query? Ask Our Experts:
https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/cell-lysis-market-103348
Strategic Acquisitions by Key Players to Fuel Market Competition
With cell-based research and therapies gaining traction in the medical & healthcare industries, key players in this market are directing their investments towards strengthening their portfolios with advanced offerings. Companies are, therefore, making strategic acquisitions to bolster their product lineups, expanding their market footprint in the process.
Industry Development:
November 2020: Beckman Coulter Life Sciences inked an agreement to purchase a German micro-bioreactor manufacturer, m2p-labs. According to Beckman Coulter, the acquisition complements its existing product portfolios dealing in cell health, laboratory automation, and liquid handling.
What are the key segments in the market?
By Product Type
- Instruments
o High-pressure Homogeniser
o Sonicator
o French Press
o Microfluidizer
o Bead Mill
o Others
- Reagents & Consumables
By Cell Type
- Mammalian Cells
- Plant Cells
- Bacterial Cells
- Others (Yeast/Algae/Fungi)
ByApplication
- Protein Isolation
- Cell Organelle Isolation
- Nucleic Acid Isolation
- Others
By End-User
- Academics & Research Institutes
- Hospitals & Diagnostic Labs
- Pharmaceutical & Biotechnology Companies
- Others
By Geography
- North America (USA, Canada)
- Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
- Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
- Latin America (Brazil, Mexico, Rest of Latin America)
- Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)
With tables and figures helping analyse worldwide Global cell lysis Market Forecast provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/cell-lysis-market-103348
SECONDARY RESEARCH IS CONDUCTED TO DERIVE THE FOLLOWING INFORMATION:
- Details such as revenues, market share, strategies, growth rate, product & their pricing by region/country for all major companies
- Details in relation to prevalence, incidence, patient numbers, distribution of patients, average price of treatment, etc.
- Number of end user facilities by region/country and average annual spending or procurement of devices by type of end user facility
- Number of procedures and average price of procedures
- Replacement rate and pricing of capital equipment
- Market dynamics in relation to the market under focus – Drivers, restraints, trends, and opportunities
- Market & technological trends, new product developments, product pipeline.
Have a Look at Related Reports:
COVID-19 Diagnostics Market Size, Share & Industry Analysis, By Product (Instruments and Reagents & Kits), By Technology (PCR (Polymerase Chain Reaction), ELISA, Point-of-care (POC), and Others), By Sample Type, By End User, and Regional Forecast, 2020-2027
In Vitro Diagnostics Market Size, Share & Industry Analysis, By Product Type (Instruments, Reagents & Consumables), By Technique ,By Application, By End User and Regional Forecast, 2019-2026
Cardiovascular Devices Market Size, Share and Industry Analysis, By Device Type (Diagnostic and Monitoring Devices, and Therapeutic and Surgical Devices), By Application (Coronary Artery Disease (CAD), Cardiac Arrhythmia, Heart Failure, and Others), By End User (Hospitals, Specialty Clinics, and Others), and Regional Forecast, 2019-2026
Polymerase Chain Reaction (PCR) Market Size, Share & Industry Analysis, By Type (Standard PCR, Real-time PCR, and Digital PCR), By Product ,By Indication ,By End User (Hospitals & Clinics, Pharmaceutical & Biotechnology Industries, Diagnostic Centers, and Academic & Research Organizations), and Regional Forecast, 2019-2026
Electronic Health Records (EHR) Market Size, Share & Industry Analysis, By Product (Web-based, On-premise), By Type (Stand Alone, Integrated) By End User (Physician’s Office, Hospitals, Others) and Regional Forecast, 2019-2026
About Us:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights™
LinkedIn | Twitter | Blogs